<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell Dev. Biol.</journal-id>
<journal-title>Frontiers in Cell and Developmental Biology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell Dev. Biol.</abbrev-journal-title>
<issn pub-type="epub">2296-634X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1496244</article-id>
<article-id pub-id-type="doi">10.3389/fcell.2024.1496244</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cell and Developmental Biology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>
<italic>Frataxin</italic> is essential for zebrafish embryogenesis and pronephros formation</article-title>
<alt-title alt-title-type="left-running-head">Ercanbrack et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcell.2024.1496244">10.3389/fcell.2024.1496244</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Ercanbrack</surname>
<given-names>Wesley S.</given-names>
</name>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2843433/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dungan</surname>
<given-names>Austin</given-names>
</name>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2842884/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gaul</surname>
<given-names>Ella</given-names>
</name>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2887059/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ramirez</surname>
<given-names>Mateo</given-names>
</name>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2887109/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>J. DelVecchio</surname>
<given-names>Alexander</given-names>
</name>
<xref ref-type="fn" rid="fn2">
<sup>&#x2021;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/Visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Grass</surname>
<given-names>Calvin</given-names>
</name>
<xref ref-type="fn" rid="fn2">
<sup>&#x2021;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2887012/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/Visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wingert</surname>
<given-names>Rebecca A.</given-names>
</name>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/395510/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<institution>Department of Biological Sciences</institution>, <institution>University of Notre Dame</institution>, <addr-line>Notre Dame</addr-line>, <addr-line>IN</addr-line>, <country>United States</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/163095/overview">James Alan Marrs</ext-link>, Indiana University, Purdue University Indianapolis, United States</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/22637/overview">antionette latrece Williams</ext-link>, University of Michigan, United States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/121098/overview">Natascia Tiso</ext-link>, University of Padua, Italy</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1291108/overview">Alessandro Luciani</ext-link>, University of Zurich, Switzerland</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Rebecca A. Wingert, <email>rwingert@nd.edu</email>; Wesley S. Ercanbrack, <email>wercanbr@nd.edu</email>
</corresp>
<fn fn-type="equal" id="fn1">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this work and share second authorship</p>
</fn>
<fn fn-type="equal" id="fn2">
<label>
<sup>&#x2021;</sup>
</label>
<p>These authors have contributed equally to this work and share third authorship</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>11</day>
<month>12</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>12</volume>
<elocation-id>1496244</elocation-id>
<history>
<date date-type="received">
<day>14</day>
<month>09</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>10</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Ercanbrack, Dungan, Gaul, Ramirez, J. DelVecchio, Grass and Wingert.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Ercanbrack, Dungan, Gaul, Ramirez, J. DelVecchio, Grass and Wingert</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background and objectives</title>
<p>Friedreich&#x2019;s Ataxia (FRDA) is a genetic disease that affects a variety of different tissues. The disease is caused by a mutation in the <italic>frataxin</italic> gene (<italic>FXN)</italic> which is important for the synthesis of iron-sulfur clusters. The primary pathologies of FRDA are loss of motor control and cardiomyopathy. These occur due to the accumulation of reactive oxygen species (ROS) in the brain and the heart due to their high metabolic rates. Our research aims to understand how developmental processes and the kidney are impacted by a deficiency of <italic>FXN</italic>.</p>
</sec>
<sec>
<title>Methods</title>
<p>We utilized an antisense oligomer, or morpholino, to knockdown the <italic>frataxin</italic> gene (<italic>fxn</italic>) in zebrafish embryos. Knockdown was confirmed via RT-PCR, gel electrophoresis, and Sanger sequencing. To investigate phenotypes, we utilized several staining techniques including whole mount <italic>in situ</italic> hybridization, Alcian blue, and acridine orange, as well as dextran-FITC clearance assays.</p>
</sec>
<sec>
<title>Results</title>
<p>
<italic>fxn</italic> deficient animals displayed otolith malformations, edema, and reduced survival. Alcian blue staining revealed craniofacial defects in <italic>fxn</italic> deficient animals, and gene expression studies showed that the pronephros, or embryonic kidney, had several morphological defects. We investigated the function of the pronephros through clearance assays and found that the renal function is disrupted in <italic>fxn</italic> deficient animals in addition to proximal tubule endocytosis. Utilizing acridine orange staining, we found that cell death is a partial contributor to these phenotypes.</p>
</sec>
<sec>
<title>Discussion and conclusion</title>
<p>This work provides new insights about how <italic>fxn</italic> deficiency impacts development and kidney morphogenesis. Additionally, this work establishes an additional model system to study FRDA.</p>
</sec>
</abstract>
<kwd-group>
<kwd>frataxin</kwd>
<kwd>kidney</kwd>
<kwd>nephron</kwd>
<kwd>metabolism</kwd>
<kwd>development</kwd>
<kwd>zebrafish</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Embryonic Development</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Friedreich&#x2019;s Ataxia (FRDA, OMIM &#x23;<ext-link ext-link-type="Omim" xlink:href="229300">229300</ext-link>) is an autosomal recessive neurodegenerative disease and the most common inheritable ataxia (<xref ref-type="bibr" rid="B5">Anheim et al., 2010</xref>; <xref ref-type="bibr" rid="B6">Anheim et al., 2012</xref>). FRDA is caused by genetic mutations that reduce expression of the protein Frataxin (FXN). The vast majority (96%&#x2013;98%) of patients have variable numbers of trinucleotide GAA repeats in the first intron of the <italic>FXN</italic> gene, though genetic lesions encoding other mutations have also been identified (<xref ref-type="bibr" rid="B70">Reetz et al., 2018</xref>; <xref ref-type="bibr" rid="B91">Gottesfeld, 2019</xref>). Patients typically begin losing motor function between 5 and 15 years of age (<xref ref-type="bibr" rid="B17">Delatycki et al., 1999</xref>; <xref ref-type="bibr" rid="B22">D&#xfc;rr et al., 1996</xref>; <xref ref-type="bibr" rid="B27">Filla et al., 1990</xref>; <xref ref-type="bibr" rid="B59">Parkinson et al., 2013</xref>; <xref ref-type="bibr" rid="B73">Sch&#xf6;ls et al., 1997</xref>), which is thought to be due to cerebellar and dorsal root ganglia degeneration (<xref ref-type="bibr" rid="B44">Koeppen et al., 2011</xref>; <xref ref-type="bibr" rid="B45">Koeppen and Mazurkiewicz, 2013</xref>). Other neurological symptoms include dysarthria, oculomotor abnormalities and hearing loss (<xref ref-type="bibr" rid="B25">Fahey et al., 2008</xref>; <xref ref-type="bibr" rid="B73">Sch&#xf6;ls et al., 1997</xref>). While the previously mentioned symptoms are primarily neurological, there are many FRDA symptoms that are not. Scoliosis, foot deformities, and cardiomyopathy are the most common, non-ataxia symptoms of FRDA (<xref ref-type="bibr" rid="B70">Reetz et al., 2018</xref>). Interestingly, each of these phenotypes are positively correlated in severity and occurrence with the number of GAA repeat expansions in intron 1 of <italic>FXN</italic> (<xref ref-type="bibr" rid="B28">Filla et al., 1996</xref>; <xref ref-type="bibr" rid="B70">Reetz et al., 2018</xref>).</p>
<p>FXN is a mitochondrial protein involved in the biosynthesis of iron-sulfur clusters (ISC) (<xref ref-type="bibr" rid="B3">Adinolfi et al., 2002</xref>; <xref ref-type="bibr" rid="B2">Adinolfi et al., 2009</xref>; <xref ref-type="bibr" rid="B15">Colin et al., 2013</xref>; <xref ref-type="bibr" rid="B34">Huynen et al., 2001</xref>; <xref ref-type="bibr" rid="B56">M&#xfc;hlenhoff et al., 2002</xref>; <xref ref-type="bibr" rid="B77">Tsai and Barondeau, 2010</xref>; <xref ref-type="bibr" rid="B80">Ventura et al., 2006</xref>). ISCs are used to make proteins for the electron transport chain, citric acid cycle, fatty acid biosynthesis, and glycolysis (<xref ref-type="bibr" rid="B52">Maio and Rouault, 2022</xref>). For example, ISCs are critical cofactors for aconitase and electron transport chain complexes I, II, and III. Decreased FXN levels lessen antioxidant defenses and the accrual of unused iron generates free radicals. Together, these changes cause cells to accumulate oxidative damage (<xref ref-type="bibr" rid="B58">Pallard&#xf3; et al., 2021</xref>; <xref ref-type="bibr" rid="B76">Sivakumar and Cherqui, 2022</xref>; <xref ref-type="bibr" rid="B39">Kelek&#xe7;i et al., 2022</xref>). Cell death is thought to transpire from this damage and insufficient energy (ATP) production (<xref ref-type="bibr" rid="B58">Pallard&#xf3; et al., 2021</xref>; <xref ref-type="bibr" rid="B76">Sivakumar and Cherqui, 2022</xref>; <xref ref-type="bibr" rid="B39">Kelek&#xe7;i et al., 2022</xref>). Tissues with high metabolic demands that are rich in mitochondria, like neurons and myocardium, are disproportionately affected over time (<xref ref-type="bibr" rid="B47">Koutnikova et al., 1997</xref>). However, other organs with high metabolic demands, like the kidney (<xref ref-type="bibr" rid="B23">Elia, 1992</xref>), are seemingly unaffected in FRDA. This is quite surprising, as related ataxias and mitochondrial disorders are very frequently characterized by renal diseases, such as the nephrotic syndrome (<xref ref-type="bibr" rid="B55">Mart&#xed;n-Hern&#xe1;ndez et al., 2005</xref>; <xref ref-type="bibr" rid="B20">Diomedi-Camassei et al., 2007</xref>; <xref ref-type="bibr" rid="B68">Quinzii and Hirano, 2010</xref>; <xref ref-type="bibr" rid="B24">Emma et al., 2012</xref>; <xref ref-type="bibr" rid="B7">Ashraf et al., 2013</xref>). As such, much still remains to be learned about how FXN deficiency affects many tissues, organs, and systems across the body.</p>
<p>Researchers have utilized several different model organisms to study the biological functions of FXN. Bacteria, yeast, plants, worms, and flies have allowed for important discoveries about its roles (<xref ref-type="bibr" rid="B9">Busi et al., 2006</xref>; <xref ref-type="bibr" rid="B39">Kelek&#xe7;i et al., 2022</xref>; <xref ref-type="bibr" rid="B56">M&#xfc;hlenhoff et al., 2002</xref>), as well as knockdown mouse models, knockdown mouse fibroblast cell cultures, and FRDA patient cell cultures (<xref ref-type="bibr" rid="B39">Kelek&#xe7;i et al., 2022</xref>; <xref ref-type="bibr" rid="B63">Perdomini et al., 2013</xref>). In particular, murine models include a useful array of various partial or conditional <italic>Fxn</italic> knockdown strategies, the latter including tissue-specific models which enable analysis of the effects of FXN-deficiency on particular cell types. Complete knockout of <italic>Fxn</italic> is embryonic lethal in mice (<xref ref-type="bibr" rid="B16">Coss&#xe9;e et al., 2000</xref>), which has precluded assessment of the early developmental roles for FXN in mammals. Mouse fibroblast <italic>Fxn</italic> deletions also lead to cell death (<xref ref-type="bibr" rid="B10">Calmels et al., 2009</xref>). These studies coincide with the observation that no FRDA patients have been reported to be homozygous with deleterious point mutations which would result in a complete absence of FXN (<xref ref-type="bibr" rid="B63">Perdomini et al., 2013</xref>).</p>
<p>In the present study, we utilized the zebrafish, <italic>Danio rerio</italic>, to study the consequence of severe <italic>fxn</italic> loss of function during ontogeny, as this animal model provides unique opportunities to examine the events of early embryogenesis. Zebrafish develop externally in clear chorions which allows for direct observation of vertebrate development beginning at fertilization. Further, the zebrafish genome is highly conserved with humans (<xref ref-type="bibr" rid="B33">Howe et al., 2013</xref>) and shares many of the genetic regulatory mechanisms that govern development, as well as many physiological and cellular processes.</p>
<p>Here, we designed a knockdown zebrafish model to specifically target and reduce zygotic <italic>fxn</italic> expression while preserving the expression of maternal <italic>fxn</italic> transcripts, thus enabling development in the context of attenuated Fxn levels. In this model, we found that <italic>fxn-</italic>deficient zebrafish exhibited poor growth and failure to thrive, with compromised survival. Additionally, <italic>fxn-</italic>deficient zebrafish embryos exhibited morphological defects across numerous tissues including the central nervous system, otoliths, craniofacial structures, and the pronephros, or embryonic kidney. Within the kidney, multiple lineages were reduced, which was associated with elevated cell death and correlated with compromised ability to clear fluid and maintain water homeostasis, leading to edema. These findings illustrate that <italic>fxn</italic> plays roles in the formation of the kidney, and this new loss of function model provides an opportunity to further delineate the roles of <italic>fxn</italic> during vertebrate development.</p>
</sec>
<sec sec-type="results" id="s2">
<title>2 Results</title>
<sec id="s2-1">
<title>2.1 Molecular and computational validation of <italic>Fxn</italic> deficiency</title>
<p>A complete <italic>Fxn</italic> knockout in mice is embryonic lethal (<xref ref-type="bibr" rid="B16">Coss&#xe9;e et al., 2000</xref>). As a result, several conditional <italic>Fxn</italic> knockdown mouse models have been developed (<xref ref-type="bibr" rid="B39">Kelek&#xe7;i et al., 2022</xref>). Studies using these conditional mouse models have suggested that <italic>Fxn</italic> may have roles in development (<xref ref-type="bibr" rid="B13">Chandran et al., 2017</xref>; <xref ref-type="bibr" rid="B36">Jiralerspong et al., 1997</xref>; <xref ref-type="bibr" rid="B43">Koeppen et al., 2017</xref>; <xref ref-type="bibr" rid="B72">Santos et al., 2001</xref>). These mouse models as well as work in systems ranging from bacterial to FRDA patient derived cell lines have contributed greatly to our understanding of FRDA pathology, but they have a limited ability to answer the question of how FXN deficiency impacts early aspects of embryonic development such as organogenesis.</p>
<p>To address this question, we developed a <italic>fxn</italic> knockdown zebrafish model using an antisense oligomer morpholino strategy to specifically target zygotic <italic>fxn</italic> expression, thereby preserving expression from maternal <italic>fxn</italic> transcripts. This model allows us to model Fxn deficiency in the zebrafish, rather than a complete Fxn absence, similar to what is seen in human patients that experience a reduction of FXN (<xref ref-type="bibr" rid="B28">Filla et al., 1996</xref>; <xref ref-type="bibr" rid="B29">Gellera et al., 2007</xref>). Our morpholino (MO) targets the exon 3 splice donor site, thus was predicted to interfere with proper connection between the exon 3 and exon 4 coding sequence (<xref ref-type="fig" rid="F1">Figure 1A</xref>). Wild-type zebrafish were microinjected with <italic>fxn</italic> MO at the 1 cell stage, and at the 28 somite stage (ss) we employed reverse transcriptase polymerase chain reaction (RT-PCR) followed by gel electrophoresis (<xref ref-type="fig" rid="F1">Figure 1B</xref>) and Sanger sequencing (<xref ref-type="fig" rid="F1">Figure 1C</xref>) to scrutinize the effect on <italic>fxn</italic> transcripts. While wild-type controls exhibited normal splicing, embryos injected with the <italic>fxn</italic> exon 3 splice donor MO exhibited exon skipping. Morphant transcripts had a complete deletion of exon 3 and exon 2 was spliced onto exon 4 (<xref ref-type="fig" rid="F1">Figure 1C</xref>). This aberrant splicing event resulted in a predicted frameshift of the open reading frame and the presence of an in-frame premature stop codon near the beginning of exon 4 (<xref ref-type="fig" rid="F1">Figure 1C</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>An antisense morpholino oligomer targeting the exon 3 and exon 4 splice region is sufficient to completely knockdown <italic>fxn</italic> expression in zebrafish. <bold>(A)</bold> A schematic of the <italic>fxn</italic> gene with annotations showing the morpholino and primer locations. <bold>(B)</bold> After cDNA synthesis using RT-PCR, analysis of the products through gel electrophoresis revealed that morphant animals produced a shorter <italic>fxn</italic> transcript and a wild-type product was absent. <bold>(C)</bold> Sanger sequencing data revealed that the <italic>fxn</italic> morphant transcript had a complete deletion of exon 3, which encoded an in-frame premature stop codon (underlined). <bold>(D)</bold> Three-dimensional protein folding predictions suggested a highly disrupted Fxn protein structure based on the altered mRNA sequence caused by splice interference due to the <italic>fxn</italic> morpholino. The endogenous Fxn consists of three alpha helices and five beta sheets, and the altered Fxn consists of an alpha helix and an interdomain loop. The orange refers to the mitochondrial trafficking sequence, an area of the protein that has low confidence for the folding prediction because of the lack of conservation between species in this specific domain. These folding predictions strongly suggest that significant regions of the Fxn protein are abrogated in the morphants.</p>
</caption>
<graphic xlink:href="fcell-12-1496244-g001.tif"/>
</fig>
<p>Next, using the <italic>fxn</italic> transcript sequences expressed by wild-type and <italic>fxn</italic> morphants, we employed the protein folding prediction algorithms Alphafold 2 and Phyre 2 to predict the three-dimensional structure of the Fxn protein (<xref ref-type="fig" rid="F1">Figure 1D</xref>; <xref ref-type="bibr" rid="B40">Kelley et al., 2015</xref>; <xref ref-type="bibr" rid="B37">Jumper et al., 2021</xref>). This approach was utilized because at this time there is currently no x-ray crystallography data for zebrafish Fxn, and we wanted to visualize how the <italic>fxn</italic> transcript alteration would disrupt the Fxn protein structure. The two algorithms predicted similar structures for both the endogenous Fxn protein and the product of our zygotic Fxn knockdown, but with critical differences (<xref ref-type="fig" rid="F1">Figure 1D</xref>). The endogenous immature Fxn protein predictions consist of three alpha helices and five beta-sheets (<xref ref-type="fig" rid="F1">Figure 1D</xref>). This is consistent with the x-ray crystallography data of mature human Fxn which has two alpha helices and five beta-sheets (<xref ref-type="bibr" rid="B19">Dhe-Paganon et al., 2000</xref>). In contrast, the zygotic Fxn protein knockdown was predicted by the algorithms to have only one alpha helix (<xref ref-type="fig" rid="F1">Figure 1D</xref>). Therefore, the algorithm predictions suggest that the morpholino would not only disrupt the three-dimensional structure of zebrafish Fxn, but indeed abrogate the active site due to the location of the premature stop codon.</p>
</sec>
<sec id="s2-2">
<title>2.2 Distinct FRDA phenotypes are present in <italic>Fxn-</italic>deficient zebrafish</title>
<p>In human patients with FRDA, multiple cell types are affected. Over time, there is considerable neuronal degeneration in the central and peripheral nervous systems and many patients experience severe hypertrophic cardiomyopathy, which is the most common cause of death (<xref ref-type="bibr" rid="B45">Koeppen and Mazurkiewicz, 2013</xref>; <xref ref-type="bibr" rid="B46">Koeppen et al., 2015</xref>). These neural and cardiac phenotypes have been recapitulated in <italic>Fxn-</italic>deficient mouse lines as well (<xref ref-type="bibr" rid="B13">Chandran et al., 2017</xref>).</p>
<p>To explore and characterize development in <italic>fxn-</italic>deficient zebrafish, we first examined their live morphology at 24, 48, and 72&#xa0;h post fertilization (hpf) (<xref ref-type="fig" rid="F2">Figure 2A</xref>). We observed several striking phenotypes in <italic>fxn</italic> morphants compared to wild-type embryos. At 24 hpf, 96.3% of <italic>fxn-</italic>deficient embryos had a gray head pallor, a hallmark of cell death (<xref ref-type="fig" rid="F2">Figures 2A,B</xref>). Also, 22.9% of the <italic>fxn-</italic>deficient embryos displayed hallmarks of malformed ear development, with three otoliths at 30 hpf compared to wild-type controls who formed otic vesicles with two otoliths (<xref ref-type="bibr" rid="B85">Whitfield, 2019</xref>) (<xref ref-type="fig" rid="F2">Figures 2A,C</xref>). At 48 hpf, 76.4% of the <italic>fxn-</italic>deficient embryos had blood pooling in or near the pericardium which was often present with pericardial edema, the latter of which is one hallmark of renal dysfunction (<xref ref-type="fig" rid="F2">Figures 2A,D</xref>). At 72 hpf, pericardial edema/blood pooling was present in 38.1% of the morphant animals (<xref ref-type="fig" rid="F2">Figures 2A,D</xref>). Further, the majority of <italic>fxn-</italic>deficient embryos exhibited overt jaw malformations, where jaws were significantly smaller in size (<xref ref-type="fig" rid="F2">Figure 2A</xref>). To better examine facial structure and jaw development, we performed Alcian blue staining to reveal the underlying cartilaginous cranial structures at 4 days post fertilization (dpf) (<xref ref-type="fig" rid="F2">Figures 2F,G</xref>). We found that 85.7% of the morphants failed to develop ceratobranchials 1-5 by 4 dpf (<xref ref-type="fig" rid="F2">Figures 2F,G</xref>). The mandibular prominence in these animals also had a convex curve when visualized laterally, rather than a concave curve that follows the profile of the maxillary prominence. Additionally, the Meckel&#x2019;s cartilage also failed to fuse medially (<xref ref-type="fig" rid="F2">Figure 2G</xref>). These data strongly suggest that <italic>fxn</italic> expression is required for the proper development of the pharyngeal arches and ceratobranchials.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Morphological analysis of <italic>fxn-</italic>deficient zebrafish embryos reveal phenotypes indicative of several developmental malformations. <bold>(A)</bold> Brightfield microscopy revealed a diffuse gray pallor in the cranium of 24 hpf <italic>fxn</italic> morphants as well as blood pooling and pericardial edema at the 48 and 72 hpf stages. Insets show otolith malformations in the <italic>fxn</italic> morphants. Scale bars &#x3d; 50 um. <bold>(B&#x2013;F)</bold> Penetrance of observed phenotypes. <bold>(B)</bold> Gray pallor at 24 hpf. <bold>(C)</bold> Otolith malformations at 30 hpf. Edema/blood pooling at <bold>(D)</bold> 48 hpf and <bold>(E)</bold> 72 hpf. <bold>(F)</bold> Ceratobranchial malformations at 4 dpf. <bold>(G)</bold> Alcian blue staining revealed ceratobranchials 1-5 were missing in <italic>fxn</italic> morphants. Additionally, Meckel&#x2019;s cartilage failed to fuse and the mandibular prominence did not curve ventrally as it does in wild-type animals. Scale bars &#x3d; 50 um. <bold>(H)</bold> Kaplan-Meier survival curve documenting survival in wild-type embryos compared to <italic>fxn</italic> morphants. <italic>Fxn</italic> morphant animals displayed a 64% chance of survival compared to the 94% chance of their wild-type siblings during the first 12 days of life.</p>
</caption>
<graphic xlink:href="fcell-12-1496244-g002.tif"/>
</fig>
<p>Finally, we noted that as <italic>fxn-</italic>deficient zebrafish developed between 24 and 72 hpf, they displayed a shorter tip to tail length compared to wild-type embryos, suggestive that their growth was being compromised wherein they displayed a general failure to thrive (<xref ref-type="fig" rid="F2">Figure 2A</xref>). Given this observation, we examined whether <italic>fxn</italic> deficiency would impact survival. Over the course of 12&#xa0;days, <italic>fxn-</italic>deficient embryos exhibited a 64% chance of survival as opposed to wild-type controls that by comparison had a 94% chance (<xref ref-type="fig" rid="F2">Figure 2H</xref>). These data strongly suggest that <italic>fxn</italic> deficiency disrupts the proper development of zebrafish embryos and their transition to a healthy larval stage of ontogeny.</p>
</sec>
<sec id="s2-3">
<title>2.3 <italic>Fxn</italic> is required for proper pronephros morphogenesis</title>
<p>The nervous system, heart, and kidneys have high metabolic rates. This would cause one to hypothesize that all of these tissues would be affected in FRDA patients as well as FXN-deficient mammalian models. Further, FXN is abundantly expressed in the embryonic and adult mouse kidney (<xref ref-type="bibr" rid="B89">Yue et al., 2014</xref>). However, kidney function has not been reported to be affected in the lifespan of FRDA patients (<xref ref-type="bibr" rid="B70">Reetz et al., 2018</xref>; <xref ref-type="bibr" rid="B74">Shinnick et al., 2016</xref>; <xref ref-type="bibr" rid="B81">Watters et al., 1981</xref>) and has similarly not been observed in animal models. This paradox, even more puzzling given the compromised fluid balance with severe edema observed in our <italic>fxn-</italic>deficient zebrafish embryos which are hallmarks of compromised renal physiology (<xref ref-type="bibr" rid="B21">Drummond et al., 1998</xref>; <xref ref-type="bibr" rid="B86">Wingert and Davidson, 2008</xref>; <xref ref-type="bibr" rid="B30">Gerlach and Wingert, 2013</xref>; <xref ref-type="bibr" rid="B18">Desgrange and Cereghini, 2015</xref>; <xref ref-type="bibr" rid="B64">Poureetezadi and Wingert, 2016</xref>; <xref ref-type="bibr" rid="B26">Fatma et al., 2021</xref>), led us to investigate next the formation and function of the zebrafish pronephros.</p>
<p>To do this, we utilized whole mount <italic>in situ</italic> hybridization (WISH) to visualize the different domains of the zebrafish pronephros at the 28 ss with previously established specific markers of each individual cell type (<xref ref-type="fig" rid="F3">Figure 3</xref>). First, we used the <italic>nphs1</italic> probe to mark the podocytes, which are essential to form the blood filtration unit used by the embryonic nephrons (<xref ref-type="bibr" rid="B48">Kramer-Zucker et al., 2005</xref>). The area occupied by <italic>nphs1</italic> positive cells was decreased in <italic>fxn-</italic>deficient embryos compared to wild-type embryos (<xref ref-type="fig" rid="F3">Figures 3A,B</xref>). Next, cells in the proximal convoluted tubule were marked with the probe for <italic>slc20a1a</italic> (<xref ref-type="bibr" rid="B88">Wingert et al., 2007</xref>). There was no statistically significant difference in the <italic>slc20a1a</italic> domain between the two groups (<xref ref-type="fig" rid="F3">Figures 3A,B</xref>). Additionally, there was not a statistically significant difference in the proximal straight tubule domain, as marked with <italic>trpm7</italic> (<xref ref-type="fig" rid="F3">Figures 3A,B</xref>) (<xref ref-type="bibr" rid="B88">Wingert et al., 2007</xref>). Interestingly, while there was not a statistically significant difference in the domain of <italic>trpm7</italic> positive cells, the <italic>fxn-</italic>deficient embryos appeared to be expressing less of this transcript, as the stain was fainter. Next, multiciliated cells (MCC) were marked with <italic>cetn2</italic> (<xref ref-type="bibr" rid="B51">Ma and Jiang, 2007</xref>). The number of <italic>cetn2</italic> positive cells was significantly decreased in <italic>fxn-</italic>deficient embryos compared to wild-types, suggesting that were fewer MCCs developed in the pronephros. Lastly, we examined the distal tubule, which is comprised of distal early cells that express <italic>slc12a1</italic> and distal late cells that express <italic>slc12a3</italic> (<xref ref-type="bibr" rid="B88">Wingert et al., 2007</xref>). Both distal segments were significantly shorter in length in the <italic>fxn-</italic>deficient embryos compared to wild-type controls (<xref ref-type="fig" rid="F3">Figures 3A,B</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Pronephros segment development is significantly disrupted in <italic>fxn-</italic>deficient zebrafish embryos. <bold>(A)</bold> WISH experiments reveal that <italic>fxn</italic> is required for the proper formation of the podocytes, multiciliated cells (MCCs), distal early, and distal late tubule. The previously mentioned domains were visualized via the <italic>nphs1,cetn4, slc12a1,</italic> and <italic>slc12a3</italic> probes, respectively. Formation of the proximal convoluted and straight tubules, as assessed by expression of <italic>slc20a1a</italic> and <italic>trpm7</italic> revealed no significant differences between wild-type embryos and <italic>fxn</italic> morphants. Scale bars &#x003D; 50&#x00A0;um. Each boxed lateral region in the embryos corresponds to the inset, which shows a dorsal view of that corresponding area for <italic>nphs1</italic>, <italic>slc20a1a</italic>, <italic>cetn2</italic>, and <italic>slc12a1</italic> or a lateral view of the corresponding area for <italic>trpm7</italic> and <italic>slc12a3</italic>. <bold>(B)</bold> Unpaired t-tests of the phenotypes revealed by WISH. &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001.</p>
</caption>
<graphic xlink:href="fcell-12-1496244-g003.tif"/>
</fig>
<p>To further assess each of the renal populations that were significantly altered in the <italic>fxn-</italic>deficient embryos, WISH was performed using a panel of independent molecular markers for the affected cell type (<xref ref-type="fig" rid="F4">Figure 4</xref>). Specifically, we used <italic>wt1b, trim35-30-201, kcnj1a.1,</italic> and <italic>gata3</italic> to examine the podocytes, MCCs, distal early, and distal late, respectively (<xref ref-type="fig" rid="F4">Figure 4</xref>). In each case, <italic>fxn-</italic>deficient embryos displayed significant reductions in the domain occupied by these pronephros populations compared to wild-type embryos, confirming our previous conclusions about the changes to each cell type based on our initial characterization of unique markers for each lineage (<xref ref-type="fig" rid="F3">Figure 3</xref>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Further analysis of pronephros segment development in <italic>fxn-</italic>deficient zebrafish embryos confirms reductions in several cell populations. <bold>(A)</bold> WISH using the probes <italic>wt1b, trim35-30-201, kcnj1a.1,</italic> and <italic>gata3</italic> which mark the podocytes, multiciliated cells (MCCs), distal early and distal late domains respectively. <italic>Fxn</italic> morphants displayed a significant reduction in podocytes, reduction in MCC number, and reduced distal domains results with this set of markers, independently recapitulating the results shown in <xref ref-type="fig" rid="F3">Figure 3</xref>. Scale bars &#x3d; 50 um. Each boxed lateral region in the embryos corresponds to the inset, which shows a dorsal view of that corresponding area, with the exception of the <italic>gata3</italic> panels which show lateral views in the corresponding inset. <bold>(B)</bold> Unpaired t-tests demonstrating significantly affected pronephric domains in the <italic>fxn</italic> morphants. &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.005, &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0005, &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001.</p>
</caption>
<graphic xlink:href="fcell-12-1496244-g004.tif"/>
</fig>
<p>Next, we utilized WISH to examine the emergence of the podocyte, distal early and distal late lineages at 22 ss and 26 ss, timepoints which precede the completion of nephron segmentation (<xref ref-type="bibr" rid="B88">Wingert et al., 2007</xref>; <xref ref-type="bibr" rid="B87">Wingert and Davidson, 2011</xref>). Additionally, these lineages were examined at 32 hpf to examine if the appearance of each population was developmentally delayed. The podocyte lineage was significantly reduced in <italic>fxn-</italic>deficient embryos compared to wild-types at the 22 ss, 26 ss and 32 hpf (<xref ref-type="sec" rid="s11">Supplemental Figure S1</xref>). Likewise, the distal early lineage as marked by <italic>slc12a1</italic> and distal late lineage as marked by <italic>slc12a3</italic> was significantly reduced in <italic>fxn-</italic>deficient embryos compared to wild-type controls (<xref ref-type="sec" rid="s11">Supplemental Figures S2, S3</xref>). Taken together, these data suggest that <italic>fxn</italic> is critical for the proper emergence of multiple lineages within the zebrafish pronephros.</p>
<p>To further explore this notion, we performed several control studies. First, we examined whether the <italic>fxn</italic> morpholino might have off target effects, which can be associated with edema and grey cranial pallor. The p53 morpholino is well known to attenuate common off target effects of morpholinos (<xref ref-type="bibr" rid="B71">Robu et al., 2007</xref>). We observed that co-injection of the p53 morpholino with the <italic>fxn</italic> morpholino led to similar phenotypes as <italic>fxn</italic> morpholino alone (<xref ref-type="sec" rid="s11">Supplemental Figure S4</xref>), namely gray pallor in the cranium at 24&#xa0;h post fertilization and edema between 48 and 72 hpf. In light of these results, we conclude that off target effects are not a significant component of the <italic>fxn-</italic>deficient morphant phenotypes. Additionally, wild-type zebrafish were microinjected with a standard control morpholino, raised to 24 hpf, and fixed for nephron segment analysis. WISH revealed that formation of the podocytes and tubule segments were not altered due to the standard morpholino control (<xref ref-type="sec" rid="s11">Supplemental Figure S5</xref>). Taken together, these studies lead us to conclude that fxn deficiency causes specific defects in development including pronephros formation.</p>
</sec>
<sec id="s2-4">
<title>2.4 MCCs are significantly decreased at several different time points</title>
<p>Defects in MCC development have been linked to embryonic fluid imbalance such as pericardial edema (<xref ref-type="bibr" rid="B54">Marra and Wingert, 2016</xref>; <xref ref-type="bibr" rid="B53">Marra et al., 2019</xref>; <xref ref-type="bibr" rid="B12">Chambers et al., 2020b</xref>). Therefore, we next sought to assess MCC specification in <italic>fxn-</italic>deficient embryos and examined whether the MCC populace was diminished at later timepoints. To characterize MCC progenitors, we examined the expression of <italic>pax2a</italic> and <italic>jag2b</italic> at the 22 ss using WISH and quantified these populations (<xref ref-type="bibr" rid="B53">Marra et al., 2019</xref>). MCC progenitor numbers in <italic>fxn-</italic>deficient animals were significantly decreased as compared to wild-type controls (<xref ref-type="fig" rid="F5">Figures 5A,B</xref>). To examine whether the MCC populations might be diminished due to developmental delay, WISH was also performed several hours subsequent to this time point to survey the number of <italic>pax2a</italic> and <italic>jag2b</italic> expressing MCC progenitors. <italic>Fxn-</italic>deficient embryos at the 26 ss had significantly decreased <italic>pax2a&#x2b;</italic> and <italic>jag2b &#x2b;</italic> MCCs compared to wild-type controls (<xref ref-type="fig" rid="F5">Figures 5A,B</xref>). These data further support the conclusion that MCCs are not specified correctly in the absence of Fxn function.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>
<italic>Fxn-</italic>deficient zebrafish embryos form reduced multiciliated cell (MCC) progenitors. <bold>(A)</bold> WISH analysis at the 22 and 26 ss utilizing the probes <italic>pax2a</italic> and <italic>jag2b</italic> revealed that the population of MCC progenitors was significantly reduced in <italic>fxn</italic> morphants compared to wild-type control embryos. Scale bars &#x3d; 50 um. <bold>(B)</bold> Unpaired t-test of the corresponding WISH experiments in panel <bold>(A)</bold>. <bold>(C)</bold> WISH analysis at the 32 hpf time point utilized the probes <italic>trim35-30-201</italic> and <italic>cetn4,</italic> which are expressed by differentiating MCCs, and revealed that MCC numbers were still significantly reduced at this later timepoint. Scale bars &#x3d; 50 um. Each boxed lateral region in the embryos corresponds to the inset, which shows a dorsal view of that corresponding area. <bold>(D)</bold> Unpaired t-test of the corresponding WISH experiments in panel <bold>(C)</bold>. &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0005, &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001.</p>
</caption>
<graphic xlink:href="fcell-12-1496244-g005.tif"/>
</fig>
<p>To examine the progression of MCC development in the context of <italic>fxn</italic> deficiency, we conducted WISH analysis on 32 hpf animals using the <italic>trim35-30-201</italic> and <italic>cetn2</italic> riboprobes, which mark differentiating MCCs (<xref ref-type="bibr" rid="B51">Ma and Jiang, 2007</xref>; <xref ref-type="bibr" rid="B50">Liu et al., 2007</xref>; <xref ref-type="bibr" rid="B54">Marra and Wingert, 2016</xref>). While both the wild-types and <italic>fxn-</italic>deficient embryos formed MCCs that expressed these more mature markers, consistent with the ability of this lineage to differentiate, the number of <italic>trim35-30-201&#x2b;</italic> and <italic>cent2&#x2b;</italic> MCCs were significantly reduced in number in <italic>fxn-</italic>deficient embryos compared to wild-types (<xref ref-type="fig" rid="F5">Figures 5C,D</xref>). In sum, these findings suggest that fewer MCCs are patterned in the <italic>fxn-</italic>deficient pronephros.</p>
</sec>
<sec id="s2-5">
<title>2.5 The pronephros in <italic>Fxn-</italic>deficient zebrafish is dysfunctional</title>
<p>Because we observed a variety of renal cell populations being affected by <italic>fxn-</italic>deficiency, we hypothesized that pronephros dysfunction may indeed underlie the edema exhibited by <italic>fxn-</italic>deficient embryos. To test this hypothesis, we injected 36 hpf wild-type controls and <italic>fxn-</italic>deficient embryos and with 40 kD FITC-Dextran, as this compound can be utilized as a proxy to visualize and measure fluid clearance within live animals in real time (<xref ref-type="bibr" rid="B82">Weaver et al., 2022</xref>) (<xref ref-type="fig" rid="F6">Figure 6</xref>). After introduction of this tracer, embryos were imaged at 6&#xa0;h post injection (hpi) and 48 hpi to assess fluorescent intensity (<xref ref-type="fig" rid="F6">Figure 6A</xref>). As observed previously, <italic>fxn-</italic>deficient embryos developed pronounced pericardial edema over this time period (<xref ref-type="fig" rid="F6">Figure 6A</xref>). Upon analysis of the percentage fluorescent change between 6 and 48 hpi, <italic>fxn-</italic>deficient embryos displayed edema a significantly decreased ability to clear the FITC-dextran compared to wild-types (<xref ref-type="fig" rid="F6">Figure 6B</xref>).</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>
<italic>Fxn-</italic>deficient zebrafish embryos display renal clearance defects and some proximal reabsorption defects. <bold>(A)</bold> <italic>fxn</italic> morphants failed to excrete the FITC-Dextran at the same rate as their wild-type siblings. Images of the same wild-type and <italic>fxn-</italic>deficient animals 6&#xa0;hours and 48&#xa0;h after injection with the FITC-dextran. FITC-Dextran (40&#xa0;kDa) was injected around 36&#xa0;h post-fertilization. <bold>(B)</bold> An unpaired t-test of the percent fluorescent change of each animal. Percent fluorescent change was calculated using the 6&#xa0;h post injection (hpi) and 48 hpi fluorescent intensity of the same animal. <bold>(C)</bold> Morphants exhibit decreased endocytosis activity in the proximal convoluted tubule (PCT). Among the morphants, there were three primary phenotypes. Morphant animals either had endocytosis activity in two PCTs, one PCT, or neither. These findings suggest that dysfunction within the PCT segments is one contributor to the fluid imbalance observed in <italic>fxn-</italic>deficient animals. <bold>(D)</bold> The proportions of proximal convoluted tubule phenotypes in the wild-type and <italic>fxn</italic> morphant groups. Scale bars are 200 um. &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0005.</p>
</caption>
<graphic xlink:href="fcell-12-1496244-g006.tif"/>
</fig>
<p>We also used FITC-Dextran to visualize proximal convoluted tubule (PCT) endocytosis activity. (<xref ref-type="fig" rid="F6">Figure 6C</xref>). Receptor mediated endocytosis is utilized extensively by the proximal tubule to reabsorb materials in the renal filtrate (<xref ref-type="bibr" rid="B90">Anzenberger et al., 2006</xref>). While wild-type embryos exhibited robust endocytosis in the PCT of both nephrons, the <italic>fxn</italic> morphants displayed a range of reduced PCT function. Approximately 35% of <italic>fxn</italic> morphants had PCT endocytosis activity in both nephrons. However, about 25% of <italic>fxn</italic> morphants had PCT endocytosis activity in nephron only and about 40% of the <italic>fxn</italic> morphants had no PCT endocytosis in either nephron (<xref ref-type="fig" rid="F6">Figure 6D</xref>). From this, we conclude that nephron function is compromised, and thus concluded that Fxn function is necessary to achieve proper pronephros function during development.</p>
</sec>
<sec id="s2-6">
<title>2.6 Cell death is amplified in <italic>Fxn-</italic>deficient zebrafish</title>
<p>Decreased expression of FXN leading to ROS and consequent cell death is hypothesized to be a major underlying pathogenic component of FRDA, commonly affecting the nervous system (<xref ref-type="bibr" rid="B1">Abeti et al., 2016</xref>; <xref ref-type="bibr" rid="B44">Koeppen et al., 2011</xref>; <xref ref-type="bibr" rid="B45">Koeppen and Mazurkiewicz, 2013</xref>). In our morphological studies, we had observed gray pallor in the developing central nervous system of <italic>Fxn-</italic>deficient embryos, which is a harbinger of cell death (<xref ref-type="bibr" rid="B14">Cheng et al., 2015</xref>). Thus, next we sought to characterize cell survival in <italic>fxn-</italic>deficient zebrafish to test the hypothesis that <italic>Fxn</italic> loss of function was indeed causing an increase in cell death across tissues during embryogenesis.</p>
<p>To test this, we used 24 and 48 hpf <italic>Fxn-</italic>deficient embryos to perform acridine orange (AO) staining (<xref ref-type="bibr" rid="B78">Tucker and Lardelli, 2007</xref>), which is a DNA intercalating fluorescent dye that rapidly and robustly labels apoptotic cells and readily penetrates deep tissues in whole mount embryos (<xref ref-type="bibr" rid="B79">van Ham et al., 2010</xref>). Next, we quantified cell death in several regions, focusing on the brain as well as the pronephros and the heart. <italic>Fxn-</italic>deficient zebrafish had significantly more AO &#x2b; cells in the brain at both 24 and 48 hpf compared to wild-types (<xref ref-type="fig" rid="F7">Figures 7A&#x2013;D</xref>). <italic>Fxn-</italic>deficient embryos also had significantly more AO &#x2b; cells in the pronephros at 24 hpf than wild-type controls (<xref ref-type="fig" rid="F7">Figures 7A,B</xref>). At the 48 hpf time point, however, there was not a significant difference in AO &#x2b; cell number between wild-types and <italic>Fxn-</italic>deficient embryos (<xref ref-type="fig" rid="F7">Figures 7C,D</xref>). Interestingly, we did not observe AO &#x2b; cells within the heart in either wild-type or <italic>fxn-</italic>deficient embryos at 24 or 48 hpf (<xref ref-type="fig" rid="F7">Figure 7</xref>). These observations suggest that cell death is a component of the developmental defects which transpire during both pronephros and central nervous system formation, but not the heart, in <italic>fxn-</italic>deficient zebrafish.</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>Cell death is elevated in <italic>fxn-</italic>deficient zebrafish embryos. <bold>(A)</bold> Images of AO-stained animals at 24 hpf. <italic>Fxn</italic> morphants animals have significantly increased cell death in the brain and pronephros at 24 hpf and increased cell death in the brain at 48 hpf. White boxes denote the locations for the panels on the right top (brain) and right bottom (pronephros). Scale bars &#x3d; 50 um. <bold>(B)</bold> Unpaired t-tests of cell death in the brain and pronephros at 24 hpf. <bold>(C)</bold> Images of AO-stained animals at 48 hpf. White boxes denote the locations for the panels on the right top (brain) and right bottom (pronephros). Within the right top brain panel, each white box indicates a single positive cell. In <italic>fxn</italic> morphants, areas of the brain commonly had multiple cells as indicated by the white box. Scale bars &#x3d; 50 um. <bold>(D)</bold> Unpaired t-tests of cell death in the brain and pronephros at 48 hpf. &#x2a;<italic>p</italic> &#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.005, &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001.</p>
</caption>
<graphic xlink:href="fcell-12-1496244-g007.tif"/>
</fig>
</sec>
<sec id="s2-7">
<title>2.7 Pronephros segment formation is differentially compromised in fxn-deficient embryos</title>
<p>As noted previously, we found that <italic>fxn-</italic>deficient embryos were typically smaller in tip to tail length than wild-types of a comparable developmental age, suggesting compromised growth over time (<xref ref-type="fig" rid="F2">Figure 2</xref>). Thus, we wondered whether the decreases seen in the several pronephros populations like the distal tubules and MCCs were simply due to the animal being smaller. To examine this possibility, we conducted WISH using <italic>cdh17</italic>, which is a pronephros specific marker (<xref ref-type="fig" rid="F8">Figure 8</xref>). <italic>cdh17</italic> stains the length of the nephron tubules (<xref ref-type="bibr" rid="B88">Wingert et al., 2007</xref>), thus allowing us to compare the absolute length of the pronephros versus the embryo tail length from tip to tail (<xref ref-type="fig" rid="F8">Figure 8A</xref>). By measuring and comparing these lengths in 24 hpf wild-types and <italic>fxn-</italic>deficient embryos, we found that the pronephros and the tail were both significantly shorter than in <italic>fxn-</italic>deficient embryos compared to wild-type control embryos at this age (<xref ref-type="fig" rid="F8">Figure 8B</xref>). When we calculated the ratio of tail/<italic>cdh17</italic> length, <italic>fxn-</italic>deficient embryos were found to have a reduction in pronephros size that was slightly less severe than the decrease in tail length (<xref ref-type="fig" rid="F8">Figure 8B</xref>). This suggests that the pronephros undergoes a decrease in size that is very similar to the overall embryonic size decrease in <italic>fxn-</italic>deficient embryos. We also examined performed tail analysis to explore whether the decreases in distal tubule length were proportionate to the smaller pronephros size. Examination of two distal early markers (<italic>slc12a1, kcnj1a.1</italic>) and two distal late markers (<italic>slc12a3, ptgs1</italic>) revealed that the decreased lengths of these segments were approximately 25% while tail lengths were reduced by approximately 10%&#x2013;12% (<xref ref-type="sec" rid="s11">Supplemental Figure S6</xref>). This analysis reveals that the distal segments of <italic>fxn-</italic>deficient embryos are disproportionately reduced compared to the tail or the nephron overall (<xref ref-type="fig" rid="F8">Figure 8C</xref>). Future studies are needed to ascertain whether changes in regions such as the cloaca, collecting duct or Corpuscles of Stannius, endocrine glands associated with the pronephros lineage, are affected in <italic>fxn-</italic>deficient embryos and how changes in these cell types relate to the distal segment reductions.</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>Tail/pronephros tubule ratio comparisons indicate that the embryonic kidney that develops within <italic>fxn-</italic>deficient zebrafish embryos was decreased in length proportionally to the decreased in tail length. <bold>(A)</bold> WISH analysis of pronephros tubule formation as marked by <italic>cdh17</italic> revealed that this structure was shorter in <italic>fxn</italic> morphants than it is in their wild-type siblings (scale bars &#x3d; 50 um). Each boxed lateral region in the embryos corresponds to the inset, which shows an enlarged lateral view of that corresponding area. <bold>(B)</bold> Unpaired t-tests of tail length and pronephros length as marked by <italic>cdh17</italic> revealed that the length of both structures was significantly shorter in the morphants than in their wild-type siblings. An unpaired t-test of the ratios of tail and pronephros length also showed a statistically significant difference. &#x2a;<italic>p</italic> &#x3c; 0.05, <italic>p</italic> &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001. <bold>(C)</bold> <italic>fxn</italic> deficiency leads to formation of a pronephros which is decreased in size in porportion to the reduction in embryo size, however the distal segments are disporportionally reduced suggesting these lineages are uniquely affected by the loss of Fxn activity.</p>
</caption>
<graphic xlink:href="fcell-12-1496244-g008.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s3">
<title>3 Discussion</title>
<p>The roles of FXN in mammalian embryogenesis remain poorly understood. Here, we have created a new loss of function model for Fxn zygotic deficiency in the zebrafish, and utilized this paradigm to begin exploring the effects of diminished Fxn expression during vertebrate organogenesis. These studies have revealed that Fxn is required for the proper development of otolith sensory structures, pharyngeal arches, ceratobranchials, and several renal lineages that comprise the nephron functional units within the pronephros. We found that cell death is significantly increased during Fxn deficiency in both the central nervous system and pronephros&#x2014;an observation which correlates with the finding that pronephros formation is differentially compromised in Fxn-deficient embryos. Lastly, we found that Fxn-deficient zebrafish embryos had an impaired ability to clear fluids. In part, fluid imbalance in <italic>Fxn</italic>-deficient zebrafish correlates to alterations in PCT reabsorption, which was compromised in &#x223c;60% of <italic>Fxn</italic>-deficient embryos. Collectively, these studies have documented a number of significant phenotypic consequences for the loss of Fxn expression during early embryonic stages of zebrafish development.</p>
<p>Interestingly, several of the tissues that are affected by Fxn deficiency during zebrafish development are also affected in animal models of FRDA and human patients as well. For example, FRDA mouse models and patients experience neuron attrition or increased cell death during neuronal differentiation (<xref ref-type="bibr" rid="B42">Koeppen, 2011</xref>; <xref ref-type="bibr" rid="B72">Santos et al., 2001</xref>; <xref ref-type="bibr" rid="B75">Simon et al., 2004</xref>), and in the present study we found that neuron survival was reduced in Fxn-deficient zebrafish embryos at 24 and 48 hpf. Although the cause of death is unknown, Fxn-deficient zebrafish embryos had a lower chance of survival than their wild-type siblings, which parallels shorter life expectancies in mouse models (<xref ref-type="bibr" rid="B62">Perdomini et al., 2014</xref>) and humans (<xref ref-type="bibr" rid="B4">Andermann et al., 1976</xref>).</p>
<p>Contrary to our findings in this report, problems stemming from craniofacial malformations, otoliths, pharyngeal arches, and ceratobranchial malformations have not been reported in other model organisms or FRDA patient studies. However, one study demonstrated that zebrafish otoliths, pharyngeal arches, and ceratobranchials are all derived from the neural crest (<xref ref-type="bibr" rid="B38">Kague et al., 2012</xref>). This may correlate with the study which demonstrated that apoptosis is increased in differentiating neuroectoderm (<xref ref-type="bibr" rid="B72">Santos et al., 2001</xref>).</p>
<p>In addition, alterations in kidney form and function have not been previously associated with FXN deficiency in other models or humans. Thus, our findings suggest for the first time that Fxn has roles in supporting embryonic kidney development. Future studies are necessary to explore whether Fxn has direct or indirect roles in the emergence, differentiation and survival of the intermediate mesoderm in higher vertebrates. Our work implicates Fxn as requisite for proper survival of renal populations. More research is needed to further understand the dynamics of cell loss, such as the mechanisms of cell death, and whether cell proliferation is compromised. The latter may be relevant given the early population changes in the podocyte, MCC and distal segments, and our observations that pronephros growth is differentially compromised in the context of Fxn deficiency.</p>
<p>In conclusion, we have created a zebrafish model of zygotic Fxn deficiency that can be utilized moving forward to expand our fundamental understanding about the developmental roles of <italic>fxn</italic>. This model is particularly well suited to examine the effects of Fxn during early ontogeny and organogenesis. Future studies are needed to create complementary genetic models of <italic>fxn</italic> loss of function using tools such as CRISPR/Cas9, and to investigate molecular changes associated with reduced Fxn levels. For example, Fxn dysfunction is closely associated with mitochondrial pathologies, which were not examined in the present work. Overall, our hope is that the fxn deficiency model described here will prove useful to other FRDA researchers in the collective effort to understand the effects of decreased FXN expression in humans, and to assist with efforts to identify new therapeutics to treat this devastating condition.</p>
</sec>
<sec sec-type="materials|methods" id="s4">
<title>4 Materials and methods</title>
<sec id="s4-1">
<title>4.1 Zebrafish husbandry</title>
<p>Zebrafish were cared for by the Freimann Life Sciences animal facility. All studies were approved by the University of Notre Dame Institutional Animal Care and Use Committee (IACUC), under protocol numbers 19&#x2013;06-5,412 and 22&#x2013;07-7,335. The T&#xfc;bingen strain was used for all our zebrafish studies. Embryos were incubated at 28&#xb0;C in E3 embryo media. Once the animals reached the relevant developmental stage (<xref ref-type="bibr" rid="B84">Westerfield, 1993</xref>), they were used for live imaging or anesthetized with 0.02% tricaine and then fixed with 4% paraformaldehyde/1x phosphate buffered saline for gene expression studies (<xref ref-type="bibr" rid="B41">Kimmel et al., 1995</xref>).</p>
</sec>
<sec id="s4-2">
<title>4.2 Morpholino knockdown</title>
<p>Morpholinos were obtained from Gene Tools, LLC. The morpholino sequence targeting the zebrafish <italic>fxn</italic> Exon 3/Exon4 splice site is 5&#x2032;-CTA&#x200b;AAT&#x200b;TTA&#x200b;CCT&#x200b;GAG&#x200b;GTG&#x200b;ATG&#x200b;TGC&#x200b;C-3&#x2019;. The morpholino was injected into zebrafish embryos at the 1 cell stage and uninjected wild-type siblings were raised as controls. The concentration and volume used are 3&#xa0;g/L and &#x223c;1.5&#xa0;nL respectively. The standard control morpholino used was 5&#x2032;-CCT&#x200b;CTT&#x200b;ACC&#x200b;TCA&#x200b;GTT&#x200b;ACA&#x200b;ATT&#x200b;TAT&#x200b;A-3&#x2019;. The p53 morpholino used was 5&#x2019; &#x2013;AGA&#x200b;ATT&#x200b;GAT&#x200b;TTT&#x200b;GCC&#x200b;GAC&#x200b;CTC&#x200b;CTC&#x200b;T-3&#x2019;.</p>
</sec>
<sec id="s4-3">
<title>4.3 RT-PCR and sanger sequencing</title>
<p>RNA was extracted from approximately 30 animals from wild-type and morphant groups using TRIZOL Invitrogen (15596026). Next, cDNA was generated using qScript cDNA Supermix (Quantabio). The primers used were: forward 5&#x2032;- TCA&#x200b;ATA&#x200b;AGT&#x200b;GGT&#x200b;GGT&#x200b;AGG&#x200b;AGT&#x200b;GTT&#x200b;T-3&#x2032;, and reverse 5&#x2032;-CCA&#x200b;GTG&#x200b;AAG&#x200b;TTT&#x200b;TCA&#x200b;TCT&#x200b;GTG&#x200b;AGA&#x200b;T-3&#x2019;. Our samples were sequenced at the University of Notre Dame Genomics and Bioinformatics Core Facility. The trace files were analyzed using 4Peaks (4Peaks by A. Griekspoor and Tom Groothuis, nucleobytes. com.)</p>
</sec>
<sec id="s4-4">
<title>4.4 Whole-mount <italic>in situ</italic> hybridization (WISH)</title>
<p>WISH was performed in the same manner as described by previous publications (<xref ref-type="bibr" rid="B11">Chambers B. E. et al., 2020</xref>; <xref ref-type="bibr" rid="B12">Chambers J. M. et al., 2020</xref>; <xref ref-type="bibr" rid="B53">Marra et al., 2019</xref>). The antisense RNA, digoxigenin-labeled probes that were used are <italic>cdh17, wt1b, nphs1, slc20a1a, trpm7, trim35-30-201, cetn4, pax2a, jag2b, slc12a1, kcnj1a.1, slc12a3,</italic> and <italic>gata3</italic>. These probes were generated using <italic>in vitro</italic> transcription from IMAGE clone templates as described by previous publications (<xref ref-type="bibr" rid="B31">Gerlach and Wingert, 2014</xref>; <xref ref-type="bibr" rid="B88">Wingert et al., 2007</xref>).</p>
</sec>
<sec id="s4-5">
<title>4.5 FITC-dextran injections</title>
<p>Wild-type and <italic>fxn</italic> morphant animals were incubated in 0.003% phenylthiourea (Sigma-Aldrich, P7629) starting at 8 hpf. Animals were anesthetized at 36 hpf with 0.02% tricaine and subsequently injected with 3&#xa0;nL of 40&#xa0;kDa FITC-Dextran (Invitrogen, D-1845) (5&#xa0;mg/mL). The injection site was around somite three in muscular tissue as described in a previous publication (<xref ref-type="bibr" rid="B49">Kroeger et al., 2017</xref>). The animals were then imaged at 6- and 48-hours post injection. The fluorescent change of the entire animal was measured using the FIJI software. The percent change of fluorescent intensity was calculated for each animal by keeping animals separate in a 96-well plate. The change in fluorescent intensity for both groups was analyzed using an unpaired t-test.</p>
</sec>
<sec id="s4-6">
<title>4.6 Acridine orange (AO)</title>
<p>Cell death was approximated using AO (Sigma-Aldrich A6014) as described in previous publications (<xref ref-type="bibr" rid="B49">Kroeger et al., 2017</xref>; <xref ref-type="bibr" rid="B82">Weaver et al., 2022</xref>). 50&#xa0;mg of AO were dissolved into 50&#xa0;mL of MilliQ water as a stock solution (100x). The stock solution was stored at &#x2212;20&#xa0;C in a light-protected container. AO was diluted down to a 1x concentration in E3 embryo medium before being applied to 24 and 48 hpf animals which had previously been incubated in 0.003% phenylthiourea starting at 8 hpf. Animals were incubated for 30&#xa0;min at room temperature in the AO/E3 solution and then washed three times over the course of 10&#xa0;min in E3. Samples were then anesthetized in a tricaine/E3 solution and immediately imaged in methylcellulose.</p>
</sec>
<sec id="s4-7">
<title>4.7 Alcian blue (AB)</title>
<p>AB (Thermofisher 05500-5G) staining was conducted as described in a previous publication (<xref ref-type="bibr" rid="B57">Neuhauss et al., 1996</xref>; <xref ref-type="bibr" rid="B82">Weaver et al., 2022</xref>). Wild-type and <italic>fxn</italic> morphants were fixed at 4 dpf using 4% paraformaldehyde at 4&#xa0;C for 16&#xa0;h. Dehydration was done using 100% methanol at &#x2212;20&#xa0;C. The rehydration was done with a series of methanol washes of decreasing concentration. Animals were bleached for 2&#xa0;h, rinsed in PBST, and then digested using a proteinase K (Roche 3115836001) (10&#xa0;mg/mL for 15&#xa0;min). Animals were then rinsed in PBST again and incubated at room temperature on a rocker for 16&#xa0;h in an Alcian Blue (0.1%), ethanol (70%), and HCl (5%) solution. The animals were then destained on a rocker in an ethanol (70%) and HCL (5%) solution for 8&#xa0;h. After destaining, the animals were washed in PBST, dehydrated in a series of ethanol washes that increased in concentration, and stored in glycerol prior to imaging.</p>
</sec>
<sec id="s4-8">
<title>4.8 Image acquisition</title>
<p>WISH, AB, AO, and live animal images were all taken on a Nikon Eclipse microscope with a DS-Fi2 camera. Methylcellulose with small amounts of tricaine was used to hold the animals in place for the live images and glycerol was used to hold the fixed animals.</p>
</sec>
<sec id="s4-9">
<title>4.9 Quantification and statistical analysis</title>
<p>All measurements were taken using the Nikon Elements imaging software on 10x images. Surface area measurements were taken using the auto-select tool. Length measurements were taken using the polyline tool. MCCs were counted manually using the binoculars on the microscope. All of the WISH data were entered into GraphPad Prism and analyzed using unpaired t-tests. AB data was analyzed using the FIJI software. AO images were analyzed by counting fluorescent cells manually. Live, brightfield images were analyzed by quantifying the phenotypes manually.</p>
</sec>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/supplementary material, and further inquires can be directed to the corresponding authors.</p>
</sec>
<sec sec-type="ethics-statement" id="s6">
<title>Ethics statement</title>
<p>The animal study was approved by University of Notre Dame IACUC. The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec sec-type="author-contributions" id="s7">
<title>Author contributions</title>
<p>WE: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Supervision, Writing&#x2013;original draft, Writing&#x2013;review and editing. AD: Data curation, Formal Analysis, Investigation, Writing&#x2013;review and editing. EG: Data curation, Formal Analysis, Investigation, Writing&#x2013;review and editing. MR: Data curation, Formal Analysis, Investigation, Writing&#x2013;review and editing. CG: Data Curation, Formal Analysis, Investigation, Writing&#x2013;review and editing. AJD: Data Curation, Formal Analysis, Investigation, Writing&#x2013;review and editing. RW: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Writing&#x2013;original draft, Writing&#x2013;review and editing.</p>
</sec>
<sec sec-type="funding-information" id="s8">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was submitted by funds to RAW from the University of Notre Dame College of Science.</p>
</sec>
<ack>
<p>The authors are grateful for the support of the Freimann Zebrafish Facility at the University of Notre Dame for the care of our animal colony, and for the services provided by the Genomics and Bioinformatics Core Facility. This work is dedicated to AH. In this study, the AI tools Alphafold 2 and Phyre 2 were used to predict protein structures.</p>
</ack>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcell.2024.1496244/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcell.2024.1496244/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.docx" id="SM1" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abeti</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Parkinson</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Hargreaves</surname>
<given-names>I. P.</given-names>
</name>
<name>
<surname>Angelova</surname>
<given-names>P. R.</given-names>
</name>
<name>
<surname>Sandi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pook</surname>
<given-names>M. A.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Mitochondrial energy imbalance and lipid peroxidation cause cell death in Friedreich&#x27;s ataxia</article-title>. <source>Cell Death Dis.</source> <volume>7</volume> (<issue>5</issue>), <fpage>e2237</fpage>. <pub-id pub-id-type="doi">10.1038/cddis.2016.111</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adinolfi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Iannuzzi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Prischi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Pastore</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Iametti</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>S. R.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Bacterial frataxin CyaY is the gatekeeper of iron-sulfur cluster formation catalyzed by IscS</article-title>. <source>Nat. Struct. Mol. Biol.</source> <volume>16</volume> (<issue>4</issue>), <fpage>390</fpage>&#x2013;<lpage>396</lpage>. <pub-id pub-id-type="doi">10.1038/nsmb.1579</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adinolfi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Trifuoggi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Politou</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pastore</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>A structural approach to understanding the iron-binding properties of phylogenetically different frataxins</article-title>. <source>Hum. Mol. Genet.</source> <volume>11</volume> (<issue>16</issue>), <fpage>1865</fpage>&#x2013;<lpage>1877</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/11.16.1865</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andermann</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Remillard</surname>
<given-names>G. M.</given-names>
</name>
<name>
<surname>Goyer</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Blitzer</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Andermann</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Barbeau</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>1976</year>). <article-title>Genetic and family studies in Friedreich&#x27;s ataxia</article-title>. <source>Can. J. Neurol. Sci.</source> <volume>3</volume> (<issue>4</issue>), <fpage>287</fpage>&#x2013;<lpage>301</lpage>. <pub-id pub-id-type="doi">10.1017/s0317167100025476</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anheim</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fleury</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Monga</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Laugel</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Chaigne</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Rodier</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Epidemiological, clinical, paraclinical and molecular study of a cohort of 102 patients affected with autosomal recessive progressive cerebellar ataxia from Alsace, Eastern France: implications for clinical management</article-title>. <source>Neurogenetics</source> <volume>11</volume> (<issue>1</issue>), <fpage>1</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1007/s10048-009-0196-y</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anheim</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tranchant</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Koenig</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>The autosomal recessive cerebellar ataxias</article-title>. <source>N. Engl. J. Med.</source> <volume>366</volume> (<issue>7</issue>), <fpage>636</fpage>&#x2013;<lpage>646</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra1006610</pub-id>
</citation>
</ref>
<ref id="B90">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anzenberger</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Bit-Avragim</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Rohr</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rudolph</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Dehmel</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Willnow</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2006</year>). <article-title>Elucidation of megalin/LRP2-dependent endocytic transport processes in the larval zebrafish pronephros</article-title>. <source>Journal of cell science</source> <volume>119</volume> (<issue>Pt 10</issue>), <fpage>2127</fpage>&#x2013;<lpage>2137</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.02954</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ashraf</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gee</surname>
<given-names>H. Y.</given-names>
</name>
<name>
<surname>Woerner</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>L. X.</given-names>
</name>
<name>
<surname>Vega-Warner</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Lovric</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption</article-title>. <source>J. Clin. Invest.</source> <volume>123</volume> (<issue>12</issue>), <fpage>5179</fpage>&#x2013;<lpage>5189</lpage>. <pub-id pub-id-type="doi">10.1172/JCI69000</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Busi</surname>
<given-names>M. V.</given-names>
</name>
<name>
<surname>Maliandi</surname>
<given-names>M. V.</given-names>
</name>
<name>
<surname>Valdez</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Clemente</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zabaleta</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>Araya</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2006</year>). <article-title>Deficiency of <italic>Arabidopsis thaliana</italic> frataxin alters activity of mitochondrial Fe-S proteins and induces oxidative stress</article-title>. <source>Plant J.</source> <volume>48</volume> (<issue>6</issue>), <fpage>873</fpage>&#x2013;<lpage>882</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-313X.2006.02923.x</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calmels</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Seznec</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Villa</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Reutenauer</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hibert</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Haiech</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Limitations in a frataxin knockdown cell model for Friedreich ataxia in a high-throughput drug screen</article-title>. <source>BMC Neurol.</source> <volume>9</volume>, <fpage>46</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2377-9-46</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chambers</surname>
<given-names>B. E.</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>E. G.</given-names>
</name>
<name>
<surname>Gatz</surname>
<given-names>A. E.</given-names>
</name>
<name>
<surname>Wingert</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>2020a</year>). <article-title>Kctd15 regulates nephron segment development by repressing Tfap2a activity</article-title>. <source>Development</source> <volume>147</volume> (<issue>23</issue>), <fpage>dev191973</fpage>. <pub-id pub-id-type="doi">10.1242/dev.191973</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chambers</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Addiego</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Flores-Mireles</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Wingert</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>2020b</year>). <article-title>Ppargc1a controls ciliated cell development by regulating prostaglandin biosynthesis</article-title>. <source>Cell Rep.</source> <volume>33</volume> (<issue>6</issue>), <fpage>108370</fpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2020.108370</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chandran</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Swarup</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Versano</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Jordan</surname>
<given-names>M. C.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Inducible and reversible phenotypes in a novel mouse model of Friedreich&#x27;s Ataxia</article-title>. <source>Elife</source> <volume>6</volume>, <fpage>e30054</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.30054</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname>
<given-names>C. N.</given-names>
</name>
<name>
<surname>Verdun</surname>
<given-names>V. A.</given-names>
</name>
<name>
<surname>Wingert</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Recent advances in elucidating the genetic mechanisms of nephrogenesis using zebrafish</article-title>. <source>Cells</source> <volume>4</volume> (<issue>2</issue>), <fpage>218</fpage>&#x2013;<lpage>233</lpage>. <pub-id pub-id-type="doi">10.3390/cells4020218</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Colin</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Martelli</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cl&#xe9;mancey</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Latour</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Gambarelli</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zeppieri</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Mammalian frataxin controls sulfur production and iron entry during <italic>de novo</italic> Fe4S4 cluster assembly</article-title>. <source>J. Am. Chem. Soc.</source> <volume>135</volume> (<issue>2</issue>), <fpage>733</fpage>&#x2013;<lpage>740</lpage>. <pub-id pub-id-type="doi">10.1021/ja308736e</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coss&#xe9;e</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Puccio</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Gansmuller</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Koutnikova</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Dierich</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>LeMeur</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2000</year>). <article-title>Inactivation of the Friedreich ataxia mouse gene leads to early embryonic lethality without iron accumulation</article-title>. <source>Hum. Mol. Genet.</source> <volume>9</volume> (<issue>8</issue>), <fpage>1219</fpage>&#x2013;<lpage>1226</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/9.8.1219</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delatycki</surname>
<given-names>M. B.</given-names>
</name>
<name>
<surname>Paris</surname>
<given-names>D. B.</given-names>
</name>
<name>
<surname>Gardner</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Nicholson</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>Nassif</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Storey</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>1999</year>). <article-title>Clinical and genetic study of Friedreich ataxia in an Australian population</article-title>. <source>Am. J. Med. Genet.</source> <volume>87</volume> (<issue>2</issue>), <fpage>168</fpage>&#x2013;<lpage>174</lpage>. <pub-id pub-id-type="doi">10.1002/(sici)1096-8628(19991119)87:2&#x3c;168::aid-ajmg8&#x3e;3.0.co;2-2</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Desgrange</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cereghini</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Nephron patterning: lessons from Xenopus, zebrafish, and mouse studies</article-title>. <source>Cells</source> <volume>4</volume> (<issue>3</issue>), <fpage>483</fpage>&#x2013;<lpage>499</lpage>. <pub-id pub-id-type="doi">10.3390/cells4030483</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dhe-Paganon</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shigeta</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Chi</surname>
<given-names>Y. I.</given-names>
</name>
<name>
<surname>Ristow</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shoelson</surname>
<given-names>S. E.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Crystal structure of human frataxin</article-title>. <source>J. Biol. Chem.</source> <volume>275</volume> (<issue>40</issue>), <fpage>30753</fpage>&#x2013;<lpage>30756</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.C000407200</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diomedi-Camassei</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Di Giandomenico</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Santorelli</surname>
<given-names>F. M.</given-names>
</name>
<name>
<surname>Caridi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Piemonte</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Montini</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2007</year>). <article-title>COQ2 nephropathy: a newly described inherited mitochondriopathy with primary renal involvement</article-title>. <source>J. Am. Soc. Nephrol.</source> <volume>18</volume> (<issue>10</issue>), <fpage>2773</fpage>&#x2013;<lpage>2780</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2006080833</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Drummond</surname>
<given-names>I. A.</given-names>
</name>
<name>
<surname>Majumdar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hentschel</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Elger</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Solnica-Krezel</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Schier</surname>
<given-names>A. F.</given-names>
</name>
<etal/>
</person-group> (<year>1998</year>). <article-title>Early development of the zebrafish pronephros and analysis of mutations affecting pronephric function</article-title>. <source>Development</source> <volume>125</volume> (<issue>23</issue>), <fpage>4655</fpage>&#x2013;<lpage>4667</lpage>. <pub-id pub-id-type="doi">10.1242/dev.125.23.4655</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>D&#xfc;rr</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cossee</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Agid</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Campuzano</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Mignard</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Penet</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>1996</year>). <article-title>Clinical and genetic abnormalities in patients with Friedreich&#x27;s ataxia</article-title>. <source>N. Engl. J. Med.</source> <volume>335</volume> (<issue>16</issue>), <fpage>1169</fpage>&#x2013;<lpage>1175</lpage>. <pub-id pub-id-type="doi">10.1056/NEJM199610173351601</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Elia</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>1992</year>). &#x201c;<article-title>Organ and tissue contribution to metabolic rate</article-title>,&#x201d; in <source>Energy metabolism: tissue determinants and cellular corollaries</source>. Editors <person-group person-group-type="editor">
<name>
<surname>Kinney,</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Tucker</surname>
<given-names>H. N.</given-names>
</name>
</person-group> (<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Raven Press, Ltd</publisher-name>), <fpage>61</fpage>&#x2013;<lpage>79</lpage>.</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Emma</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bertini</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Salviati</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Montini</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Renal involvement in mitochondrial cytopathies</article-title>. <source>Pediatr. Nephrol.</source> <volume>27</volume> (<issue>4</issue>), <fpage>539</fpage>&#x2013;<lpage>550</lpage>. <pub-id pub-id-type="doi">10.1007/s00467-011-1926-6</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fahey</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Cremer</surname>
<given-names>P. D.</given-names>
</name>
<name>
<surname>Aw</surname>
<given-names>S. T.</given-names>
</name>
<name>
<surname>Millist</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Todd</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>O. B.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>Vestibular, saccadic and fixation abnormalities in genetically confirmed Friedreich ataxia</article-title>. <source>Brain</source> <volume>131</volume> (<issue>Pt 4</issue>), <fpage>1035</fpage>&#x2013;<lpage>1045</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awm323</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fatma</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nayak</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Swain</surname>
<given-names>R. K.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Methods to generate and evaluate zebrafish models of human kidney diseases</article-title>. <source>Int. J. Dev. Biol.</source> <volume>65</volume> (<issue>7-8-9</issue>), <fpage>475</fpage>&#x2013;<lpage>485</lpage>. <pub-id pub-id-type="doi">10.1387/ijdb.210041rs</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Filla</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>DeMichele</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Caruso</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Marconi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Campanella</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>1990</year>). <article-title>Genetic data and natural history of Friedreich&#x27;s disease: a study of 80 Italian patients</article-title>. <source>J. Neurol.</source> <volume>237</volume> (<issue>6</issue>), <fpage>345</fpage>&#x2013;<lpage>351</lpage>. <pub-id pub-id-type="doi">10.1007/BF00315657</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Filla</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>De Michele</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Cavalcanti</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Pianese</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Monticelli</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Campanella</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>1996</year>). <article-title>The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia</article-title>. <source>Am. J. Hum. Genet.</source> <volume>59</volume> (<issue>3</issue>), <fpage>554</fpage>&#x2013;<lpage>560</lpage>.</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gellera</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Castellotti</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Mariotti</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mineri</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Seveso</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Didonato</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2007</year>). <article-title>Frataxin gene point mutations in Italian Friedreich ataxia patients</article-title>. <source>Neurogenetics</source> <volume>8</volume> (<issue>4</issue>), <fpage>289</fpage>&#x2013;<lpage>299</lpage>. <pub-id pub-id-type="doi">10.1007/s10048-007-0101-5</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gerlach</surname>
<given-names>G. F.</given-names>
</name>
<name>
<surname>Wingert</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Kidney organogenesis in the zebrafish: insights into vertebrate nephrogenesis and regeneration</article-title>. <source>Wiley Interdiscip. Rev. Dev. Biol.</source> <volume>2</volume> (<issue>5</issue>), <fpage>559</fpage>&#x2013;<lpage>585</lpage>. <pub-id pub-id-type="doi">10.1002/wdev.92</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gerlach</surname>
<given-names>G. F.</given-names>
</name>
<name>
<surname>Wingert</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Zebrafish pronephros tubulogenesis and epithelial identity maintenance are reliant on the polarity proteins Prkc iota and zeta</article-title>. <source>Dev. Biol.</source> <volume>396</volume> (<issue>2</issue>), <fpage>183</fpage>&#x2013;<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1016/j.ydbio.2014.08.038</pub-id>
</citation>
</ref>
<ref id="B91">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gottesfeld</surname>
<given-names>J. M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Molecular mechanisms and therapeutics for the gaa&#xb7;ttc expansion disease friedreich ataxia. neurotherapeutics</article-title>. <source>the journal of the American Society for Experimental NeuroTherapeutics</source> <volume>16</volume> (<issue>4</issue>), <fpage>1032</fpage>&#x2013;<lpage>1049</lpage>. <pub-id pub-id-type="doi">10.1007/s13311-019-00764-x</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Howe</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Torroja</surname>
<given-names>C. F.</given-names>
</name>
<name>
<surname>Torrance</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Berthelot</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Muffato</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>The zebrafish reference genome sequence and its relationship to the human genome</article-title>. <source>Nature</source> <volume>496</volume> (<issue>7446</issue>), <fpage>498</fpage>&#x2013;<lpage>503</lpage>. <pub-id pub-id-type="doi">10.1038/nature12111</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huynen</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Snel</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bork</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>T. J.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>The phylogenetic distribution of frataxin indicates a role in iron-sulfur cluster protein assembly</article-title>. <source>Hum. Mol. Genet.</source> <volume>10</volume> (<issue>21</issue>), <fpage>2463</fpage>&#x2013;<lpage>2468</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/10.21.2463</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Javed</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Davidson</surname>
<given-names>L. E.</given-names>
</name>
<name>
<surname>Thornton</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Albu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Boxt</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Brain and high metabolic rate organ mass: contributions to resting energy expenditure beyond fat-free mass</article-title>. <source>Am. J. Clin. Nutr.</source> <volume>91</volume> (<issue>4</issue>), <fpage>907</fpage>&#x2013;<lpage>912</lpage>. <pub-id pub-id-type="doi">10.3945/ajcn.2009.28512</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiralerspong</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Montermini</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Stifani</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pandolfo</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Frataxin shows developmentally regulated tissue-specific expression in the mouse embryo</article-title>. <source>Neurobiol. Dis.</source> <volume>4</volume> (<issue>2</issue>), <fpage>103</fpage>&#x2013;<lpage>113</lpage>. <pub-id pub-id-type="doi">10.1006/nbdi.1997.0139</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jumper</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Pritzel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Figurnov</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ronneberger</surname>
<given-names>O.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Highly accurate protein structure prediction with AlphaFold</article-title>. <source>Nature</source> <volume>596</volume> (<issue>7873</issue>), <fpage>583</fpage>&#x2013;<lpage>589</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-021-03819-2</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kague</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Gallagher</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Burke</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Parsons</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Franz-Odendaal</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Fisher</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Skeletogenic fate of zebrafish cranial and trunk neural crest</article-title>. <source>PLoS One</source> <volume>7</volume> (<issue>11</issue>), <fpage>e47394</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0047394</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kelek&#xe7;i</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Y&#x131;ld&#x131;z</surname>
<given-names>A. B.</given-names>
</name>
<name>
<surname>Sevin&#xe7;</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>&#xc7;imen</surname>
<given-names>D. U.</given-names>
</name>
<name>
<surname>&#xd6;nder</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Perspectives on current models of Friedreich&#x27;s ataxia</article-title>. <source>Front. Cell Dev. Biol.</source> <volume>10</volume>, <fpage>958398</fpage>. <pub-id pub-id-type="doi">10.3389/fcell.2022.958398</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kelley</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Mezulis</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yates</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Wass</surname>
<given-names>M. N.</given-names>
</name>
<name>
<surname>Sternberg</surname>
<given-names>M. J.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>The Phyre2 web portal for protein modeling, prediction and analysis</article-title>. <source>Nat. Protoc.</source> <volume>10</volume> (<issue>6</issue>), <fpage>845</fpage>&#x2013;<lpage>858</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2015.053</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kimmel</surname>
<given-names>C. B.</given-names>
</name>
<name>
<surname>Ballard</surname>
<given-names>W. W.</given-names>
</name>
<name>
<surname>Kimmel</surname>
<given-names>S. R.</given-names>
</name>
<name>
<surname>Ullmann</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Schilling</surname>
<given-names>T. F.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Stages of embryonic development of the zebrafish</article-title>. <source>Dev. Dyn.</source> <volume>203</volume> (<issue>3</issue>), <fpage>253</fpage>&#x2013;<lpage>310</lpage>. <pub-id pub-id-type="doi">10.1002/aja.1002030302</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koeppen</surname>
<given-names>A. H.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Friedreich&#x27;s ataxia: pathology, pathogenesis, and molecular genetics</article-title>. <source>J. Neurol. Sci.</source> <volume>303</volume> (<issue>1-2</issue>), <fpage>1</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2011.01.010</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koeppen</surname>
<given-names>A. H.</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>A. B.</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gelman</surname>
<given-names>B. B.</given-names>
</name>
<name>
<surname>Mazurkiewicz</surname>
<given-names>J. E.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Friedreich ataxia: developmental failure of the dorsal root entry zone</article-title>. <source>J. Neuropathol. Exp. Neurol.</source> <volume>76</volume> (<issue>11</issue>), <fpage>969</fpage>&#x2013;<lpage>977</lpage>. <pub-id pub-id-type="doi">10.1093/jnen/nlx087</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koeppen</surname>
<given-names>A. H.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>A. N.</given-names>
</name>
<name>
<surname>Morral</surname>
<given-names>J. A.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>The cerebellar component of Friedreich&#x27;s ataxia</article-title>. <source>Acta Neuropathol.</source> <volume>122</volume> (<issue>3</issue>), <fpage>323</fpage>&#x2013;<lpage>330</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-011-0844-9</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koeppen</surname>
<given-names>A. H.</given-names>
</name>
<name>
<surname>Mazurkiewicz</surname>
<given-names>J. E.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Friedreich ataxia: neuropathology revised</article-title>. <source>Exp. Neurol.</source> <volume>72</volume> (<issue>2</issue>), <fpage>78</fpage>&#x2013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1097/NEN.0b013e31827e5762</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koeppen</surname>
<given-names>A. H.</given-names>
</name>
<name>
<surname>Ramirez</surname>
<given-names>R. L.</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>A. B.</given-names>
</name>
<name>
<surname>Bjork</surname>
<given-names>S. T.</given-names>
</name>
<name>
<surname>Levi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Santambrogio</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>The pathogenesis of cardiomyopathy in Friedreich ataxia</article-title>. <source>PLoS One</source> <volume>10</volume> (<issue>3</issue>), <fpage>e0116396</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0116396</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koutnikova</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Campuzano</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Foury</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Doll&#xe9;</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Cazzalini</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Koenig</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin</article-title>. <source>Nat. Genet.</source> <volume>16</volume> (<issue>4</issue>), <fpage>345</fpage>&#x2013;<lpage>351</lpage>. <pub-id pub-id-type="doi">10.1038/ng0897-345</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kramer-Zucker</surname>
<given-names>A. G.</given-names>
</name>
<name>
<surname>Wiessner</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jensen</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Drummond</surname>
<given-names>I. A.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Organization of the pronephric filtration apparatus in zebrafish requires Nephrin, Podocin and the FERM domain protein Mosaic eyes</article-title>. <source>Dev. Biol.</source> <volume>285</volume> (<issue>2</issue>), <fpage>316</fpage>&#x2013;<lpage>329</lpage>. <pub-id pub-id-type="doi">10.1016/j.ydbio.2005.06.038</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kroeger</surname>
<given-names>P. T.</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Drummond</surname>
<given-names>B. E.</given-names>
</name>
<name>
<surname>Miceli</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>McKernan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gerlach</surname>
<given-names>G. F.</given-names>
</name>
<name>
<surname>Marra</surname>
<given-names>A. N.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>The zebrafish kidney mutant zeppelin reveals that brca2/fancd1 is essential for pronephros development</article-title>. <source>Dev. Biol.</source> <volume>428</volume> (<issue>1</issue>), <fpage>148</fpage>&#x2013;<lpage>163</lpage>. <pub-id pub-id-type="doi">10.1016/j.ydbio.2017.05.025</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Pathak</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kramer-Zucker</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Drummond</surname>
<given-names>I. A.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Notch signaling controls the differentiation of transporting epithelia and multiciliated cells in the zebrafish pronephros</article-title>. <source>Development</source> <volume>134</volume> (<issue>6</issue>), <fpage>1111</fpage>&#x2013;<lpage>1122</lpage>. <pub-id pub-id-type="doi">10.1242/dev.02806</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Y. J.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Jagged2a-notch signaling mediates cell fate choice in the zebrafish pronephric duct</article-title>. <source>PLoS Genet.</source> <volume>3</volume> (<issue>1</issue>), <fpage>e18</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.0030018</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maio</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Rouault</surname>
<given-names>T. A.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Mammalian iron sulfur cluster biogenesis and human diseases</article-title>. <source>IUBMB Life</source> <volume>74</volume> (<issue>7</issue>), <fpage>705</fpage>&#x2013;<lpage>714</lpage>. <pub-id pub-id-type="doi">10.1002/iub.2597</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marra</surname>
<given-names>A. N.</given-names>
</name>
<name>
<surname>Adeeb</surname>
<given-names>B. D.</given-names>
</name>
<name>
<surname>Chambers</surname>
<given-names>B. E.</given-names>
</name>
<name>
<surname>Drummond</surname>
<given-names>B. E.</given-names>
</name>
<name>
<surname>Ulrich</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Addiego</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Prostaglandin signaling regulates renal multiciliated cell specification and maturation</article-title>. <source>Proc. Natl. Acad. Sci. USA.</source> <volume>116</volume> (<issue>17</issue>), <fpage>8409</fpage>&#x2013;<lpage>8418</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1813492116</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marra</surname>
<given-names>A. N.</given-names>
</name>
<name>
<surname>Wingert</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Epithelial cell fate in the nephron tubule is mediated by the ETS transcription factors etv5a and etv4 during zebrafish kidney development</article-title>. <source>Dev. Biol.</source> <volume>411</volume> (<issue>2</issue>), <fpage>231</fpage>&#x2013;<lpage>245</lpage>. <pub-id pub-id-type="doi">10.1016/j.ydbio.2016.01.035</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mart&#xed;n-Hern&#xe1;ndez</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Garc&#xed;a-Silva</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Vara</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Campos</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cabello</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Muley</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>Renal pathology in children with mitochondrial diseases</article-title>. <source>Pediatr. Nephrol.</source> <volume>20</volume> (<issue>9</issue>), <fpage>1299</fpage>&#x2013;<lpage>1305</lpage>. <pub-id pub-id-type="doi">10.1007/s00467-005-1948-z</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>M&#xfc;hlenhoff</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Richhardt</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ristow</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kispal</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Lill</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>The yeast frataxin homolog Yfh1p plays a specific role in the maturation of cellular Fe/S proteins</article-title>. <source>Hum. Mol. Genet.</source> <volume>11</volume> (<issue>17</issue>), <fpage>2025</fpage>&#x2013;<lpage>2036</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/11.17.2025</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neuhauss</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Solnica-Krezel</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Schier</surname>
<given-names>A. F.</given-names>
</name>
<name>
<surname>Zwartkruis</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Stemple</surname>
<given-names>D. L.</given-names>
</name>
<name>
<surname>Malicki</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>1996</year>). <article-title>Mutations affecting craniofacial development in zebrafish</article-title>. <source>Development</source> <volume>123</volume>, <fpage>357</fpage>&#x2013;<lpage>367</lpage>. <pub-id pub-id-type="doi">10.1242/dev.123.1.357</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pallard&#xf3;</surname>
<given-names>F. V.</given-names>
</name>
<name>
<surname>Pagano</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Rodr&#xed;guez</surname>
<given-names>L. R.</given-names>
</name>
<name>
<surname>Gonzalez-Cabo</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lyakhovich</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Trifuoggi</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Friedreich Ataxia: current state-of-the-art, and future prospects for mitochondrial-focused therapies</article-title>. <source>Transl. Res.</source> <volume>229</volume>, <fpage>135</fpage>&#x2013;<lpage>141</lpage>. <pub-id pub-id-type="doi">10.1016/j.trsl.2020.08.009</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parkinson</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Boesch</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nachbauer</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Mariotti</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Giunti</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Clinical features of Friedreich&#x27;s ataxia: classical and atypical phenotypes</article-title>. <source>J. Neurochem.</source> <volume>126</volume> (<issue>Suppl. 1</issue>), <fpage>103</fpage>&#x2013;<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.12317</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perdomini</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Belbellaa</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Monassier</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Reutenauer</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Messaddeq</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Cartier</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich&#x27;s ataxia</article-title>. <source>Nat. Med.</source> <volume>20</volume> (<issue>5</issue>), <fpage>542</fpage>&#x2013;<lpage>547</lpage>. <pub-id pub-id-type="doi">10.1038/nm.3510</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perdomini</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hick</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Puccio</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Pook</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Animal and cellular models of Friedreich ataxia</article-title>. <source>J. Neurochem.</source> <volume>126</volume> (<issue>Suppl. 1</issue>), <fpage>65</fpage>&#x2013;<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.12219</pub-id>
</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poureetezadi</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Wingert</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Little fish, big catch: zebrafish as a model for kidney disease</article-title>. <source>Kidney Int.</source> <volume>89</volume> (<issue>6</issue>), <fpage>1204</fpage>&#x2013;<lpage>1210</lpage>. <pub-id pub-id-type="doi">10.1016/j.kint.2016.01.031</pub-id>
</citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Puccio</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Simon</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Coss&#xe9;e</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Criqui-Filipe</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Tiziano</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Melki</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2001</year>). <article-title>Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits</article-title>. <source>Nat. Genet.</source> <volume>27</volume> (<issue>2</issue>), <fpage>181</fpage>&#x2013;<lpage>186</lpage>. <pub-id pub-id-type="doi">10.1038/84818</pub-id>
</citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quinzii</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Hirano</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Coenzyme Q and mitochondrial disease</article-title>. <source>Dev. Disabil. Res. Rev.</source> <volume>16</volume> (<issue>2</issue>), <fpage>183</fpage>&#x2013;<lpage>188</lpage>. <pub-id pub-id-type="doi">10.1002/ddrr.108</pub-id>
</citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reetz</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Dogan</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Hohenfeld</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Didszun</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Giunti</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mariotti</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Nonataxia symptoms in friedreich ataxia: report from the registry of the European friedreich&#x27;s ataxia consortium for translational studies (EFACTS)</article-title>. <source>Neurology</source> <volume>91</volume> (<issue>10</issue>), <fpage>e917</fpage>&#x2013;<lpage>e930</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0000000000006121</pub-id>
</citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robu</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Larson</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Nasevicius</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Beiraghi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Brenner</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Farber</surname>
<given-names>S. A.</given-names>
</name>
<etal/>
</person-group> (<year>2007</year>). <article-title>p53 activation by knockdown technologies</article-title>. <source>PLoS Genet.</source> <volume>3</volume> (<issue>5</issue>), <fpage>e78</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.0030078</pub-id>
</citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santos</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Ohshima</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Pandolfo</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Frataxin deficiency enhances apoptosis in cells differentiating into neuroectoderm</article-title>. <source>Hum. Mol. Genet.</source> <volume>10</volume> (<issue>18</issue>), <fpage>1935</fpage>&#x2013;<lpage>1944</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/10.18.1935</pub-id>
</citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sch&#xf6;ls</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Amoiridis</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Przuntek</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Frank</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Epplen</surname>
<given-names>J. T.</given-names>
</name>
<name>
<surname>Epplen</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Friedreich&#x27;s ataxia. Revision of the phenotype according to molecular genetics</article-title>. <source>Brain</source> <volume>120</volume> (<issue>Pt 12</issue>), <fpage>2131</fpage>&#x2013;<lpage>2140</lpage>. <pub-id pub-id-type="doi">10.1093/brain/120.12.2131</pub-id>
</citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shinnick</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Isaacs</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Vivaldi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Schadt</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lynch</surname>
<given-names>D. R.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Friedreich Ataxia and nephrotic syndrome: a series of two patients</article-title>. <source>BMC Neurol.</source> <volume>16</volume>, <fpage>3</fpage>. <pub-id pub-id-type="doi">10.1186/s12883-016-0526-2</pub-id>
</citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simon</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Seznec</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Gansmuller</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Carelle</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Weber</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Metzger</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>Friedreich ataxia mouse models with progressive cerebellar and sensory ataxia reveal autophagic neurodegeneration in dorsal root ganglia</article-title>. <source>J. Neurosci.</source> <volume>24</volume> (<issue>8</issue>), <fpage>1987</fpage>&#x2013;<lpage>1995</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4549-03.2004</pub-id>
</citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sivakumar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cherqui</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Advantages and limitations of gene therapy and gene editing for Friedreich&#x27;s Ataxia</article-title>. <source>Front. Genome</source> <volume>4</volume>, <fpage>903139</fpage>. <pub-id pub-id-type="doi">10.3389/fgeed.2022.903139</pub-id>
</citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsai</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Barondeau</surname>
<given-names>D. P.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Human frataxin is an allosteric switch that activates the Fe-S cluster biosynthetic complex</article-title>. <source>Biochemistry</source> <volume>49</volume> (<issue>43</issue>), <fpage>9132</fpage>&#x2013;<lpage>9139</lpage>. <pub-id pub-id-type="doi">10.1021/bi1013062</pub-id>
</citation>
</ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tucker</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Lardelli</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>A rapid apoptosis assay measuring relative acridine orange fluorescence in zebrafish embryos</article-title>. <source>Zebrafish</source> <volume>4</volume> (<issue>2</issue>), <fpage>113</fpage>&#x2013;<lpage>116</lpage>. <pub-id pub-id-type="doi">10.1089/zeb.2007.0508</pub-id>
</citation>
</ref>
<ref id="B79">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Ham</surname>
<given-names>T. J.</given-names>
</name>
<name>
<surname>Mapes</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kokel</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Peterson</surname>
<given-names>R. T.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Live imaging of apoptotic cells in zebrafish</article-title>. <source>FASEB J.</source> <volume>24</volume> (<issue>11</issue>), <fpage>4336</fpage>&#x2013;<lpage>4342</lpage>. <pub-id pub-id-type="doi">10.1096/fj.10-161018</pub-id>
</citation>
</ref>
<ref id="B80">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ventura</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Rea</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Testi</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Long-lived <italic>C. elegans</italic> mitochondrial mutants as a model for human mitochondrial-associated diseases</article-title>. <source>Exp. Gerontol.</source> <volume>41</volume> (<issue>10</issue>), <fpage>974</fpage>&#x2013;<lpage>991</lpage>. <pub-id pub-id-type="doi">10.1016/j.exger.2006.06.060</pub-id>
</citation>
</ref>
<ref id="B81">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watters</surname>
<given-names>G. V.</given-names>
</name>
<name>
<surname>Zlotkin</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Kaplan</surname>
<given-names>B. S.</given-names>
</name>
<name>
<surname>Humphreys</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Drummond</surname>
<given-names>K. N.</given-names>
</name>
</person-group> (<year>1981</year>). <article-title>Friedreich&#x27;s ataxia with nephrotic syndrome and convulsive disorder: clinical and neurophysiological studies with renal and nerve biopsies and an autopsy</article-title>. <source>Can. J. Neurol. Sci.</source> <volume>8</volume> (<issue>1</issue>), <fpage>55</fpage>&#x2013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1017/s0317167100042852</pub-id>
</citation>
</ref>
<ref id="B82">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weaver</surname>
<given-names>N. E.</given-names>
</name>
<name>
<surname>Healy</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wingert</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Gldc is essential for renal progenitor patterning during kidney development</article-title>. <source>Biomedicines</source> <volume>10</volume> (<issue>12</issue>), <fpage>3220</fpage>. <pub-id pub-id-type="doi">10.3390/biomedicines10123220</pub-id>
</citation>
</ref>
<ref id="B84">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Westerfield</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>1993</year>). <source>The zebrafish book</source>. <publisher-loc>Eugene</publisher-loc>: <publisher-name>University of Oregon Press</publisher-name>.</citation>
</ref>
<ref id="B85">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Whitfield</surname>
<given-names>T. T.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Cilia in the developing zebrafish ear</article-title>. <source>Philos. Trans. R. Soc. Lond. B Biol. Sci.</source> <volume>375</volume> (<issue>1792</issue>), <fpage>20190163</fpage>. <pub-id pub-id-type="doi">10.1098/rstb.2019.0163</pub-id>
</citation>
</ref>
<ref id="B86">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wingert</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Davidson</surname>
<given-names>A. J.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>The zebrafish pronephros: a model to study nephron segmentation</article-title>. <source>Kidney Int.</source> <volume>73</volume> (<issue>10</issue>), <fpage>1120</fpage>&#x2013;<lpage>1127</lpage>. <pub-id pub-id-type="doi">10.1038/ki.2008.37</pub-id>
</citation>
</ref>
<ref id="B87">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wingert</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Davidson</surname>
<given-names>A. J.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Zebrafish nephrogenesis involves dynamic spatiotemporal expression changes in renal progenitors and essential signals from retinoic acid and irx3b</article-title>. <source>Dev. Dyn.</source> <volume>240</volume> (<issue>8</issue>), <fpage>2011</fpage>&#x2013;<lpage>2027</lpage>. <pub-id pub-id-type="doi">10.1002/dvdy.22691</pub-id>
</citation>
</ref>
<ref id="B88">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wingert</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Selleck</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>H. D.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2007</year>). <article-title>The cdx genes and retinoic acid control the positioning and segmentation of the zebrafish pronephros</article-title>. <source>PLoS Genet.</source> <volume>3</volume> (<issue>10</issue>), <fpage>1922</fpage>&#x2013;<lpage>1938</lpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.0030189</pub-id>
</citation>
</ref>
<ref id="B89">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yue</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Breschi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Vierstra</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ryba</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>A comparative encyclopedia of DNA elements in the mouse genome</article-title>. <source>Nature</source> <volume>515</volume> (<issue>7527</issue>), <fpage>355</fpage>&#x2013;<lpage>364</lpage>. <pub-id pub-id-type="doi">10.1038/nature13992</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>